Targeting the TNFR2 oncogene on tumor cells and tregs of the tumor microenvironment via dominant TNFR2 antagonism.

被引：0
|
作者：
Faustman, Denise L.
Torrey, Heather
Butterworth, John
Mera, Toshi
Okubo, Yoshiaki
Wang, Limei
Baum, Danielle
Warden, Sara
Plager, Sarah
Huang, Daniel
Vanamee, Eva
Foster, Rosemary
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 07期
关键词：
D O I：
10.1200/JCO.2017.35.7_suppl.106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106
引用
收藏
页数：1
相关论文
共 50 条
  • [11] An immunocytokine consisting of a TNFR2 agonist and TNFR2 scFv enhances the expansion of regulatory T cells through TNFR2 clustering
    Inoue, Masaki
    Tsuji, Yuta
    Kashiwada, Ayaka
    Yokoyama, Asahi
    Iwata, Akane
    Abe, Yasuhiro
    Kamada, Haruhiko
    Tsunoda, Shin-ichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 697
  • [12] Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome
    H Torrey
    M Khodadoust
    L Tran
    D Baum
    A Defusco
    Y H Kim
    D L Faustman
    Leukemia, 2019, 33 : 1206 - 1218
  • [13] TNFR2 expression by Tregs is critical for suppressing tumor immunity by regulating inflammatory cytokines
    Hilaire, Morgane
    Koshravi, Maryam
    Mimoun, Angelina
    Ronin, Emilie
    Richer, Wilfrid
    Cagnet, Leonie
    Kassem, Sahar
    Boissonnas, Alexandre
    Bonnin, Elisa
    Piaggio, Eliane
    Salomon, Benoit L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 438 - 438
  • [14] Harnessing the Expression of TNFR2 on Tregs to Prevent Agvhd
    Vargas, Juan Gamboa
    Kanzler, Carla
    Scheller, Lukas
    Kreckel, Jennifer
    Shaikh, Haroon
    Lang, Isabell
    Medler, Juliane
    Anany, Mohamed
    Steinfatt, Tim
    Hartweg, Julia
    Haack, Stefanie
    Holler, Ernst
    Buettner-Herold, Maike
    Gaviria, Paula Tabares
    Wajant, Harald
    Beilhack, Andreas
    Einsele, Hermann
    BLOOD, 2022, 140 : 4465 - 4466
  • [15] Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies
    Torrey, Heather
    Defusco, Audrey
    Baum, Danielle
    Rahbar, Ziba
    Khodadoust, Michael
    Kim, Youn H.
    Faustman, Denise
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [16] Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies
    Torrey, Heather
    Defusco, Audrey
    Baum, Danielle
    Rhabar, Ziba
    Khodadoust, Michael
    Kim, Youn H.
    Faustman, Denise L.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [17] Direct oncogene cancer killing and selective tumor Treg killing through the TNFR2 receptor via dominant antibody antagonists
    Torrey, Heather
    Butterworth, John
    Mera, Toshi
    Okubo, Yoshiaki
    Wang, Limei
    Baum, Danielle
    Warden, Sarah
    Plager, Sara
    Huang, Daniel
    Vanamee, Eva
    Foster, Rosemary
    Faustman, Denise
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [18] Novel TNFR2 humanized mouse model for human TNFR2 antibody evaluation
    Guo, Yanan
    Li, Yanan
    Zhou, Xiaofei
    Su, Youhong
    Lin, Qingcong
    CANCER RESEARCH, 2020, 80 (16)
  • [19] The role of tumor necrosis factor receptor 2 (TNFR2) in EAE
    Arena, Maria Montes De Oca
    Bartsch, Brenden
    Schwegman, Lance
    Abdul-Baki, Nawal
    Forsthuber, Thomas
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [20] Tumor necrosis factor α promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2
    Tanimura, Y
    Kokuryo, T
    Tsunoda, N
    Yamazaki, Y
    Oda, K
    Nimura, Y
    Mon, NN
    Huang, PY
    Nakanuma, Y
    Chen, MF
    Jan, YY
    Yeh, TS
    Chiu, CT
    Hsieh, LL
    Hamaguchi, M
    CANCER LETTERS, 2005, 219 (02) : 205 - 213
12345